Year |
Citation |
Score |
2013 |
Niemitz E. Tumor suppressors, oncogenes and aneuploidy Nature Genetics. 45: 1417-1417. DOI: 10.1038/ng.2841 |
0.346 |
|
2005 |
Niemitz EL, Feinberg AP, Brandenburg SA, Grundy PE, DeBaun MR. Children with idiopathic hemihypertrophy and beckwith-wiedemann syndrome have different constitutional epigenotypes associated with wilms tumor. American Journal of Human Genetics. 77: 887-91. PMID 16252245 DOI: 10.1086/497540 |
0.629 |
|
2004 |
Niemitz EL, DeBaun MR, Fallon J, Murakami K, Kugoh H, Oshimura M, Feinberg AP. Microdeletion of LIT1 in familial Beckwith-Wiedemann syndrome. American Journal of Human Genetics. 75: 844-9. PMID 15372379 DOI: 10.1086/425343 |
0.622 |
|
2004 |
Niemitz EL, Feinberg AP. Epigenetics and assisted reproductive technology: a call for investigation. American Journal of Human Genetics. 74: 599-609. PMID 14991528 DOI: 10.1086/382897 |
0.543 |
|
2003 |
DeBaun MR, Niemitz EL, Feinberg AP. Association of in vitro fertilization with Beckwith-Wiedemann syndrome and epigenetic alterations of LIT1 and H19. American Journal of Human Genetics. 72: 156-60. PMID 12439823 DOI: 10.1086/346031 |
0.565 |
|
2002 |
Loukinov DI, Pugacheva E, Vatolin S, Pack SD, Moon H, Chernukhin I, Mannan P, Larsson E, Kanduri C, Vostrov AA, Cui H, Niemitz EL, Rasko JE, Docquier FM, Kistler M, et al. BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma. Proceedings of the National Academy of Sciences of the United States of America. 99: 6806-11. PMID 12011441 DOI: 10.1073/Pnas.092123699 |
0.607 |
|
2002 |
DeBaun MR, Niemitz EL, McNeil DE, Brandenburg SA, Lee MP, Feinberg AP. Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. American Journal of Human Genetics. 70: 604-11. PMID 11813134 DOI: 10.1086/338934 |
0.597 |
|
2001 |
Ravenel JD, Broman KW, Perlman EJ, Niemitz EL, Jayawardena TM, Bell DW, Haber DA, Uejima H, Feinberg AP. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor. Journal of the National Cancer Institute. 93: 1698-703. PMID 11717330 DOI: 10.1093/Jnci/93.22.1698 |
0.561 |
|
2001 |
Cui H, Niemitz EL, Ravenel JD, Onyango P, Brandenburg SA, Lobanenkov VV, Feinberg AP. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site. Cancer Research. 61: 4947-50. PMID 11431321 |
0.575 |
|
Show low-probability matches. |